Annual
Results
for the year ended
30 June
2022
RE-IMAGINING
THE HEALTHCARE
SYSTEM
THE HEALTHCARE
SYSTEM
| EXCEL DOWNLOAD |
| % change |
Year ended 30 June 2022 R'000 |
Year ended 30 June 2021 R'000 |
|
| Revenue from contracts with customers | 8,0 | 8 722 570 | 8 074 418 |
|---|---|---|---|
| Dividends received | — | 1 000 | |
| Fair value gains/(losses) | 6 369 | (6 307) | |
| Finance income | 15 086 | 19 595 | |
| Other income | 563 | 3 061 | |
| Total income | 8,1 | 8 744 588 | 8 091 767 |
| Cost of distribution of pharmaceutical products | (98 694) | (95 991) | |
| Cost of pharmaceutical products and finished goods | (2 022 726) | (1 809 606) | |
| Employee benefit costs | (2 364 724) | (2 278 354) | |
| Other expenses | (2 879 641) | (2 628 627) | |
| Amortisation | (231 269) | (195 027) | |
| Rent and property costs | (96 089) | (90 914) | |
| Right of use assets depreciation | (63 287) | (66 564) | |
| Depreciation | (87 299) | (78 202) | |
| IT costs | (152 416) | (62 994) | |
| Write off of intangibles | (635) | (26 793) | |
| Impairment of intangibles | — | (42 349) | |
| Reversal of impairment of intangibles | — | 39 167 | |
| Impairment of loans | (3 203) | (7 196) | |
| Share of profits from associates and joint ventures | 6 991 | 8 294 | |
| Interest on lease liabilities | (19 354) | (21 420) | |
| Finance costs | (57 049) | (35 673) | |
| Profit before tax | (3.5) | 675 193 | 699 518 |
| Income tax expense – continuing operations | (6.0) | (193 453) | (205 741) |
| Profit from continuing operations | (2.4) | 481 740 | 493 777 |
| Loss from discontinued operations (NOTE 3) | — | (14 008) | |
| Loss on disposal of subsidiaries (NOTE 3) | — | (10 014) | |
| Profit for the year | 2.6 | 481 740 | 469 755 |
| Profit for the year attributable to: | |||
| Owners of Parent | 314 276 | 302 033 | |
| Non-controlling interest | 167 464 | 167 722 | |
| 481 740 | 469 755 | ||
| Profit for the year attributable to equity shareholders arises from: | |||
| Continuing operations | 314 276 | 316 041 | |
| Discontinued operations | — | (14 008) | |
| 314 276 | 302 033 | ||
| Profit for the year | 481 740 | 469 755 | |
| Other comprehensive income | |||
| Components of other comprehensive income that will not be reclassified to profit or loss | |||
| Remeasurement of post-employment benefit obligations | (24) | 179 | |
| Income tax relating to these items | 6 | (50) | |
| Total other comprehensive income that will not be reclassified to profit or loss | (18) | 129 | |
| Components of other comprehensive income that will be reclassified to profit or loss | |||
| Exchange differences on translation of foreign operations | |||
| Foreign exchange benefit/(loss) of continuing operations | 1 519 | (5 636) | |
| Foreign exchange benefit of discontinued operations | — | 11 658 | |
| Total other comprehensive income that will be reclassified to profit or loss | 1 519 | 6 022 | |
| Total other comprehensive income net of tax | 1 501 | 6 151 | |
| Total comprehensive income | 1.5 | 483 241 | 475 906 |
| Comprehensive income attributable to: | |||
| Comprehensive income, attributable to owners of parent | 315 341 | 310 655 | |
| Comprehensive income, attributable to non-controlling interests | 167 900 | 165 251 | |
| 483 241 | 475 906 |
| * | The above Consolidated Statement of Comprehensive Income is reflected in a similar format to the Annual Financial Statements. For a comparative view to operating performance in line with previous years, refer to the supplementary information. |